Home / Antidoping Lab Qatar (ADLQ)

Antidoping Lab Qatar (ADLQ)

Site

Antidoping Lab Qatar (ADLQ)

Accreditation No.

19306

Site No.

22003

Date of Accreditation

24 Dec 2013

Address

Sports City Road, Aspire Zone, PO Box 27775, DOHA
0
Qatar

adlqatar.net

Contact

Dr Alka Beotra P: 97 444132915

Availability

Services not available to external clients

Scope of Accreditation

Print scopes

Antidoping Lab Qatar (ADLQ)

ISO/IEC 17025 (2017)

Healthcare, Pharmaceutical and Media Products

Service	Product	Determinant	Technique	Procedure
Analysis for physical and chemical characteristics of human and veterinary medicines including vaccines	Dietary supplements	1-Androstenediol; 1-Androstenedione; 1-Testosterone; 16-Dehydroprogesterone; 19-Norandrostenedione; 4-Androstenediol; 4-Hydroxytestosterone; 5-Androsten-3α, 17β-diol; 5α-Androstane-3α, 17β-diol; 5β-Androstane-3α, 17β-diol; Adrafinil; Amfepramone; Aminoglutethimide; Amphetamine; Androst-5-ene-3β, 17β-diol; Androstanolone (5α-DHT); Androsterone; Arimistane; Beclometasone; Benfluorex; Benzphetamine; Benzylpiperazine (BZP, 1-benzylpiperazine); Betamethasone; Bolasterone; Boldenone; Boldione; Budesonide; Buprenorphine; Calusterone; Carphedon; Clenbuterol; Clobenzorex; Clobetasol; Clostebol; Cropropamide; Crotetamide; Danazol; Dehydroepiandrosterone (DHEA); Desonide; Dexamethasone; Dimetamphetamine; Drostanolone; Epiandrosterone; Epitestosterone; Etamivan; Ethylestrenol; Etiocholanolone; Fenbutrazate; Fencamfamin; Fencamine; Fenfluramine; Fenoterol; Fludrocortisone; Flumetasone; Fluorometholone; Fluoxymesterone; Formestane; Formoterol; Furazabol; Furfenorex; Heptaminol; Hydromorphone; Isometheptene; Mephedrone; Mephentermine; Mestanolone; Mesterolone; Metandienone; Metenolone; Methandriol; Methasterone; Methyl-1-testosterone; Methylamphetamine; Methylclostebol; Methylhexaneamine; Methylstenbolone; Mibolerone; Modafinil; Nandrolone; Norboletone; Norethandrolone; Norfenfluramine; Oxabolone; Oxandrolone; Oxycodone; Oxymesterone; Oxymetholone; Oxymorphone; Pentazocine; Phendimetrazine; Pipradol; Prednisolone; Prednisone; Prenylamine; Progesterone; Prolintane; Raloxifene; Salmeterol; Sibutramine; Stenbolone; Strychnine; Synephrine; Tadalafil; Tamoxifen; Testosterone; Tibolone; Tramadol; Triamcinolone acetonide; Turinabol; p-Methylamphetamine; α-Zeranol; β-Zeranol	GC-MS; GC-MS-MS; LC-MS-MS	in house method LAB SOP152

ISO/IEC 17025 (2017)

Legal - Analysis for compliance with WADA and sporting federation requirements

This facility complies with the requirements of the World Anti-Doping Agency (WADA) International Standard for Laboratories (ISL) (January 2021)

Service	Product	Determinant	Technique	Procedure
Analysis for sports drugs and drug metabolites	Human blood	M1: Manipulation of blood and blood components (blood analysis for the haematological model for athlete biological passport); S2: Peptide hormones, growth factors, related substances, and mimetics	Electrical impedance; Flow cytometry; Lysation; Sysmex XN 1000	in-house method SOP 109: Quantitative CP
		Human growth hormone (HGH); S2: Peptide hormones, growth factors, related substances, and mimetics (human growth hormone - isoform)	Affinity-binding assay	in-house method SOP 107:ITP, Quantitative CP
	Human blood; Human urine	Benzodiazepines; Erythropoietin (EPO) stimulating agents; S2: Peptide hormones, growth factors, related substances, and mimetics (erythropoiesis stimulating agents - SAR-PAGE, IEF-PAGE)	Gel electrophoresis; Immunoblot; Immunopurification	in-house method SOP 104
	Human serum	S2: Peptide hormones, growth factors, related substances, and mimetics	Affinity-binding assay; Chemiluminescent immunoassay	in-house method LAB SOP108c: ITP
		S2: Peptide hormones, growth factors, related substances, and mimetics	LC-MSn (n≥1)	in-house method Lab SOP 108b: ITP, Quantitative CP
		S2: Peptide hormones, growth factors, related substances, and mimetics	Affinity-binding assay	in-house method Lab SOP 108a: ITP, Quantitative CP
		S1: Anabolic agents	LC-MSn (n≥1)	in-house method Lab SOP 127
	Human urine	Luteinising hormone (LH); S2: Peptide hormones, growth factors, related substances, and mimetics	Affinity-binding assay	in-house method SOP 118: ITP, Qualitative CP
		S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone)	Affinity-binding assay	in-house method SOP 103:ITP, Quanitative CP
		pH	Potentiometric	in-house method SOP 015
		Ephedrine; S6: Stimulants	Dilute and shoot; LC-HRMSn (n≥1)	in-house method SOP 120:Quantitative CP
		Formoterol; S3: Beta-2 agonists	Enzymatic hydrolysis; LC-MSn (n≥1)	in-house method SOP 124:Quantitative CP
		S1: Anabolic agents	Derivatization; GC-MSn (n≥1); Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS); Liquid chromatography (LC); Liquid liquid extraction; Solid phase extraction (SPE)	in-house method SOP 105:Quantitative CP
		M1: Manipulation of blood and blood components; P1: Beta-blockers; S1: Anabolic agents; S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone); S3: Beta-2 agonists; S4: Hormone and metabolic modulators; S5: Diuretics and masking agents; S6: Stimulants; S7: Narcotics; S8: Cannabinoids; S9: Glucocorticoids	Derivatization; Enzymatic hydrolysis; GC-MSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction	in-house method SOP 102: ITP, Qualitative CP
		Plasma volume expanders; S5: Diuretics and masking agents	GC-MSn (n≥1); LC-MSn (n≥1)	in-house method SOP 106:ITP, Qualitative CP
		Specific gravity	Refractometry	in-house method SOP 009
		11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; S8: Cannabinoids	Enzymatic hydrolysis; LC-MSn (n≥1)	in-house method SOP 121:Quantitative CP
		Blood parameters; S1: Anabolic agents (including steroid profiling)	Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-MSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE)	in-house method SOP 125:Quantitative CP
		Ethylglucuronide (ETG)	Dilute and shoot; LC-MSn (n≥1)	in-house method SOP 113
		Morphine; S7: Narcotics	Enzymatic hydrolysis; LC-MSn (n≥1)	in-house method SOP 122:Quantitative CP
		19-Norandrosterone (19-NA); S1: Anabolic agents	Derivatization; Enzymatic hydrolysis; GC-MSn (n≥1); Liquid liquid extraction	in-house method SOP 119:Qualitative CP
		S3: Beta-2 agonists; Salbutamol	Enzymatic hydrolysis; LC-MSn (n≥1)	in-house method SOP 123:Quantitative CP
		Cobalt	Dilute and shoot; ICP-MS	in-house method SOP 126
		S2: Peptide hormones, growth factors, related substances, and mimetics; Small peptides	LC-MSn (n≥1); Solid phase extraction (SPE)	in-house method SOP 115:ITP, Qualitative CP

ISO/IEC 17025 (2017)

Legal

Service	Product	Determinant
Medico legal drug testing	Urine	Benzodiazepines
		Opiates
		Tricyclic antidepressants (TCAs)
		Methadone; Stimulants
		Δ-9-Tetrahydrocannabinol (THC-Δ9)
Monitoring of animals for drugs, metabolites and other substances - Quantitative analysis	Equine plasma	Carbon dioxide - Total; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
	Equine plasma; Equine urine	Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Salicylic acid; Theobromine
		Dimethylsulfoxide; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
		Agonists; Anabolic agents; Anti-inflammatories; Antidepressants; Corticosteroids; Diuretics; Masking agents; Metabolic modulators; Muscle relaxants; Narcotics; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Sedatives; Stimulants; β-Blockers
		Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Testosterone
	Equine urine	Arsenic; Cobalt
		Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules; Small peptides
		3-Methoxytyramine; Cortisol; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
		Boldenone; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules
		Arsenic; Quantitative analysis of prohibited substances (and their metabolites and artefacts) as defined by the International Federation of Horseracing Authorities and by National and State Racing Authority Rules

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.